Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vanda Pharmaceuticals (VNDA) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Vanda Pharmaceuticals (VNDA) over the last 16 years, with Q4 2025 value amounting to 0.38%.

  • Vanda Pharmaceuticals' Return on Capital Employed fell 3000.0% to 0.38% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.38%, marking a year-over-year decrease of 3000.0%. This contributed to the annual value of 0.35% for FY2025, which is 2800.0% down from last year.
  • As of Q4 2025, Vanda Pharmaceuticals' Return on Capital Employed stood at 0.38%, which was down 3000.0% from 0.24% recorded in Q3 2025.
  • Over the past 5 years, Vanda Pharmaceuticals' Return on Capital Employed peaked at 0.09% during Q3 2021, and registered a low of 0.38% during Q4 2025.
  • Over the past 5 years, Vanda Pharmaceuticals' median Return on Capital Employed value was 0.01% (recorded in 2022), while the average stood at 0.04%.
  • Per our database at Business Quant, Vanda Pharmaceuticals' Return on Capital Employed surged by 400bps in 2021 and then tumbled by -3000bps in 2025.
  • Quarter analysis of 5 years shows Vanda Pharmaceuticals' Return on Capital Employed stood at 0.08% in 2021, then plummeted by -86bps to 0.01% in 2022, then plummeted by -312bps to 0.03% in 2023, then plummeted by -195bps to 0.07% in 2024, then tumbled by -412bps to 0.38% in 2025.
  • Its Return on Capital Employed was 0.38% in Q4 2025, compared to 0.24% in Q3 2025 and 0.2% in Q2 2025.